创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

YANG Jianhong, ZHANG Yanyan, LI Changqing, YAO Peiying, CHEN Jiangpeng, LYU Xinhuan, XIAO Yao, ZHANG Xianglin. Suggestions on Improving the Management System of China's Ethics Committee[J]. Progress in Pharmaceutical Sciences, 2021, 45(9): 663-668.
Citation: YANG Jianhong, ZHANG Yanyan, LI Changqing, YAO Peiying, CHEN Jiangpeng, LYU Xinhuan, XIAO Yao, ZHANG Xianglin. Suggestions on Improving the Management System of China's Ethics Committee[J]. Progress in Pharmaceutical Sciences, 2021, 45(9): 663-668.

Suggestions on Improving the Management System of China's Ethics Committee

  • Based on the research on the management system of Ethics Committee in other countries and regions in the world, its current situation in China, and the results of interviews with experts and questionnaires, this paper puts forward some suggestions on the quality of ethical review in China, the efficiency of Ethics Committee review, beginning time for ethics review, the order of clinical review, ethical review of innovative drugs, and supervision of Ethics Committees, aiming to provide reference for perfecting the management system of Ethics Committee in China.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return